Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity

Cancer

Volumn 122, Issue 16, 2016, Pages 2479-2486

  Joseph, Djenaba A ^a   Meester, Reinier G S ^b   Zauber, Ann G ^c   Manninen, Diane L ^d   Winges, Linda ^d   Dong, Fred B ^d   Peaker, Brandy ^e   van Ballegooijen, Marjolein ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d BATTELLE MEMORIAL INSTITUTE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

capacity; colonoscopy; colorectal cancer screening

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLONOSCOPY; COLONOSCOPY CAPACITY; COLONOSCOPY CURRENT VOLUME; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; DISEASE SURVEILLANCE; FECAL IMMUNOCHEMICAL TESTING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; IMMUNOCHEMISTRY; MASS SCREENING; MICROSIMULATION SCREENING ANALYSIS COLON MODEL; MODEL; OCCULT BLOOD TEST; POPULATION SIZE; PRIORITY JOURNAL; PROGRAM EVALUATION; SCREENING TEST; SENSITIVITY ANALYSIS; SIGMOIDOSCOPY; TIME;

EID: 84982986855     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30070     Document Type: Article

References (39)

1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2012 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2015. Available at: www.cdc.gov/uscs.
2. U.S. Preventive Service Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627–637.
3. National Center for Health Statistics. Data File Documentation, National Health Interview Survey, 2010 (Machine Readable Data File and Documentation). Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; 2014.
4. Meester RGS, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015;121:2281–2285.
5. Fedewa SA, Ma J, Sauer AG, et al. How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018? Cancer. 2015;121:4258–4265.
6. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, Wilschut JA, Zauber AG, van Ballegooijen. Stool DNA testing to screen for colorectal cancer in the Medicare population. Ann Intern Med. 2010;153:368–377.
7. Cancer Intervention and Surveillance Modeling Network. Colorectal cancer model profiles. http://cisnet.cancer.gov/colorectal/profiles.html. Accessed March 31, 2014.
8. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36:2251–2270.
9. United States Census Bureau. Population projections. http://www.census.gov/population/projections/. Accessed February 2014.
10. Disario JA, Foutch PG, Mai HD, Pardy K, Manne RK. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol. 1991;86:941–945.
11. Johnson DA, Gurney MS, Volpe RJ, et al. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with and age-related risk. Am J Gastroenterol. 1990;85:969–974.
12. Koretz RL. Malignant polyps: are they sheep in wolves' clothing? Ann Intern Med. 1993;118:63–68.
13. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol. 1991;86:946–951.
14. Rex DK, Lehman GA, Hawes RH, Ulbright TM, Smith JJ. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology. 1991;100:64–67.
15. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence—SEER 9 Regs Public Use. Nov 2003 Sub (1973–2001), DCCPS, Surveillance Research Program, Cancer Statistics Branch. Based on the November 2003 Submission. Bethesda, MD: National Cancer Institute; 2004.
16. Berkeley Mortality Database. Data for the United States. http://www.demog.berkeley.edu/∼bmd/states.html. Accessed February 1, 2014.
17. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin. 2006;56:143–159.
18. Lieberman DA, Rex DK, Winawer SJ, Giadiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.
19. Seeff LC, Richards TB, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's Survey of Endoscopic Capacity. Gastroenterology. 2004;127:1670–1677.
20. Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012;21:895–904.
21. Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20:1611–1621.
22. Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC; Centers for Disease Control and Prevention (CDC). Colorectal cancer screening—United States, 2002, 2004, 2006, and 2008. MMWR Suppl. 2011;60:42–46.
23. Dorn SD, Wei D, Farley JF, et al. Impact of the 2008-2009 economic recession on screening colonoscopy utilization among the insured. Clin Gastroenterol Hepatol. 2012;10:278–284.
24. Koenig L, Gu Q. Growth of ambulatory surgery centers, surgery volume, and savings to Medicare. Am J Gastroenterol. 2013;108:10–15.
25. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Data. Atlanta, GA: US Department of Health and Human Services; 2012.
26. Lieberman DA, Holub J, Eisen G, Kraemer D, Morris CD. Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc. 2005;62:875–883.
27. Leiberman DA, de Garmo PL, Fleischer DE, Eisen GM, Helfand M. Patterns of endoscopy use in the United States. Gastroenterology. 2000;118:619–624.
28. Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011;171:1335–1343.
29. Sheffield KM, Han Y, Kuo YF, Riall TS, Goodwin JS. Potentially inappropriate screening colonoscopy in Medicare patients. JAMA Intern Med. 2013;173:542–550.
30. Cooper GS, Kuo TD, Barnholtz-Slaon JS, Koroukian SM, Schluchter MD. Use of colonoscopy for polyp surveillance in Medicare beneficiaries. Cancer. 2013;119:1800–1807.
31. Laiyemo AO, Pinsky PF, Marcus PM, et al. Utilization and yield of surveillance colonoscopy in the continued follow-up of the Polyp Prevention Trial. Clin Gastroenterol Hepatol. 2009;7:562–567.
32. Boolchand V, Olds G, Singh J, Singh P, Chak A, Cooper GS. Colorectal cancer screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med. 2006;145:654–659.
33. Schoen RE, Pinsky PF, Weissfeld JL, et al. Utilization of surveillance colonoscopy in community practice. Gastroenterology. 2010;138:71–81.
34. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004;141:264–271.
35. Holden D, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152:666–668.
36. Seeff LC, Royalty J, Helsel WE, et al. Clinical outcomes from the CDC's colorectal cancer screening demonstration program. Cancer. 2013;119(15 suppl):2820–2833.
37. Nadel MR, Royalty J, Shapiro JA, et al. Assessing screening quality in the CDC's colorectal cancer screening demonstration program. Cancer. 2013;119(15 suppl):2834–2841.
38. Humphrey LL, Shannon J, Partin MR, O'Malley J, Chen Z, Helfand M. Improving the follow-up of positive hemoccult screening tests: an electronic intervention. J Gen Intern Med. 2011;26:691–697.
39. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33:101–110.